SAT Platform TechnologyProduct Information
Overview
TB-SAT Mycoplasma Pneumoniae Assay
Name AmpSure® Nucleic acid test kit of Mycoplasma Pneumoniae (RNA-SAT)
Feature:Fast Diagnosis | Assess Treatment Outcome | “Viable Bacterium” Detection | Improve the Positive Rate
Detection target

Mycobacterium tuberculosis Complex RNA

Specimens Requirements

Sputum

Compatible Instruments

AutoSAT, ABI Prism 7300, ABI Prism 7500, Strangene Mx 3005, etc

Specifications

20 tests

Storage and Shelf Life

Storage: -15℃~-35℃
Shelf life: 12 months

Avoid repeated freezing and thawing.

Certificates

CE, FSC

Disease Damage

Tuberculosis - The World's Number One Killer of Infectious Disease

In 2018 the World Health Organization released 10 million new cases of TB and an estimated 1.57 million deaths in 2017.

TB co-infection with HIV accounted for 9% or 920,000 of the new cases; 560,000 people had multidrug-resistant TB.

About 1/3 of the world's population has latent TB, and the lifetime risk of TB-infected individuals falling ill with TB is 10%. In addition, TB is the number one killer of people living with HIV.


Advantages
TB-SAT test discriminate MTB from NTM
Detects Mycobacterium tuberculosis complex and distinguishes between 18 NTM species
TB-SAT is the only molecular test for viable bacterium
Mycobacterium tuberculosis die in about 7 days and all rRNA is degraded, while DNA is still present
RNA as Biomarker
High sensitivity, high specificity and almost no contamination
Clinical Application


Diagnosis of patients with suspicious symptoms of pulmonary tuberculosis

Assist assessment of clinical treatment efficacy

Tuberculosis screening for special populations

Tuberculosis screening for suspected other lung diseases or confirmation of comorbidities


Contact Information

Telephone:021-50720200

Email:sales@rdbio.com

Fax:021-50720186

Address:Block A, building 15, NO.528 Ruiqing Road, East District, Zhangjiang High Tech Park, Shanghai, P.R .China

Copyright © Shanghai Rendu Biotechnology Co.,Ltd.